Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Small Cell

Explore clinical trials studying Carcinoma, Small Cell. Study availability and eligibility vary by location and protocol.

20 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Small Cell trial results

Completed

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

NCT03092739

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • Vseobecna fakultni nemocnice v Praze; I. klinika tuberkulozy a respiracnich nemoci Prague, Czechia
  • Universitätsklinikum Göttingen, Institut für Pathologie Göttingen, Germany
  • Instytut Gruźlicy i Chorób Płuc, I Klinika Chorób Płuc Warsaw, Poland
  • Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Anatomía Patológica A Coruña, LA Coruña, Spain
View Trial Details
Completed

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

NCT00298896

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • University of California Davis Sacramento, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University Baltimore, Maryland, United States
View all 17 locations
View Trial Details
Completed

Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer

NCT00305942

Conditions
Carcinoma, Carcinoma, Small Cell, Lung Diseases, +8 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States
View all 16 locations
View Trial Details
Completed

Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer

NCT00294190

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Northeast Arkansas Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States
  • Florida Hospital Cancer Institute Orlando, Florida, United States
View all 13 locations
View Trial Details
Completed

Efficacy and Safety Study of OSI-211 (Liposomal Lurtotecan) to Treat Recurrent Small Cell Lung Cancer

NCT00046787

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +12 more
Locations
  • Arizona Clinical Research Center, Inc. Tucson, Arizona, United States
  • University of Colorado Health Sciences Center Denver, Colorado, United States
  • Baptist Hospital Regional Cancer Ctr. Knoxville, Tennessee, United States
  • Vanderbilt Clinical Trials Office Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned

NCT00191750

Conditions
Carcinoma, Carcinoma, Small Cell, Neoplasms, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Aurora, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chapel Hill, North Carolina, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Monday-Friday from 9:00 AM to 5:00 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details

Related conditions